Clariane SE (PA:CLARI) — Market Cap & Net Worth
Market Cap & Net Worth: Clariane SE (CLARI)
Clariane SE (PA:CLARI) has a market capitalization of $1.44 Billion (€1.24 Billion) as of August 1, 2026. Listed on the PA stock exchange, this France-based company holds position #7239 globally and #121 in its home market, demonstrating a 1.73% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Clariane SE's stock price €3.99 by its total outstanding shares 357286663 (357.29 Million). See Clariane SE capex to cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
Clariane SE Market Cap History: 2015 to 2026
Clariane SE's market capitalization history from 2015 to 2026. Data shows change from $6.99 Billion to $1.67 Billion (-12.49% CAGR).
Index Memberships
Clariane SE is a constituent of 6 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
CAC Mid 60
CACMD
|
$195.05 Billion | 0.74% | #35 of 55 |
|
CAC Mid & Small
CACMS
|
$231.99 Billion | 0.62% | #43 of 119 |
|
CAC All-Tradable
CACT
|
$2.85 Trillion | 0.05% | #101 of 179 |
|
CAC All-Tradable Net Total Return
CACTN
|
$2.85 Trillion | 0.05% | #101 of 179 |
|
CAC All Tradable Gross Total Return
CACTR
|
$2.85 Trillion | 0.05% | #101 of 179 |
|
CAC Health Care
FRHC
|
$250.51 Billion | 0.58% | #9 of 36 |
Weight: Clariane SE's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Clariane SE Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Clariane SE's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.31x
Clariane SE's market cap is 0.31 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1027.03x
Clariane SE's market cap is 1027.03 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $5.91 Billion | $2.98 Billion | $131.29 Million | 1.98x | 45.03x |
| 2017 | $6.37 Billion | $3.13 Billion | $163.32 Million | 2.04x | 39.03x |
| 2018 | $6.87 Billion | $3.34 Billion | $123.13 Million | 2.06x | 55.80x |
| 2019 | $9.42 Billion | $3.61 Billion | $114.68 Million | 2.61x | 82.15x |
| 2020 | $7.63 Billion | $3.77 Billion | $39.40 Million | 2.02x | 193.53x |
| 2021 | $6.84 Billion | $4.14 Billion | $91.11 Million | 1.65x | 75.07x |
| 2022 | $2.55 Billion | $4.44 Billion | $22.06 Million | 0.57x | 115.41x |
| 2023 | $626.22 Million | $5.00 Billion | -$105.25 Million | 0.13x | N/A |
| 2024 | $872.17 Million | $5.28 Billion | -$55.12 Million | 0.17x | N/A |
| 2025 | $1.64 Billion | $5.31 Billion | $1.60 Million | 0.31x | 1027.03x |
Competitor Companies of CLARI by Market Capitalization
Companies near Clariane SE in the global market cap rankings as of August 1, 2026.
Key companies related to Clariane SE by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #327 globally with a market cap of $80.16 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #905 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #994 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1356 globally with a market cap of $18.52 Billion USD ( RM73.78 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #327 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $402.59 |
| #905 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €44.52 |
| #994 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1356 | IHH Healthcare Bhd | KLSE:5225 | $18.52 Billion | RM8.35 |
Clariane SE Historical Marketcap From 2015 to 2026
Between 2015 and today, Clariane SE's market cap moved from $6.99 Billion to $ 1.67 Billion, with a yearly change of -12.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.67 Billion | +1.42% |
| 2025 | €1.64 Billion | +88.41% |
| 2024 | €872.17 Million | +39.27% |
| 2023 | €626.22 Million | -75.40% |
| 2022 | €2.55 Billion | -62.78% |
| 2021 | €6.84 Billion | -10.30% |
| 2020 | €7.63 Billion | -19.06% |
| 2019 | €9.42 Billion | +37.11% |
| 2018 | €6.87 Billion | +7.79% |
| 2017 | €6.37 Billion | +7.81% |
| 2016 | €5.91 Billion | -15.46% |
| 2015 | €6.99 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Clariane SE was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.44 Billion USD |
| MoneyControl | $1.44 Billion USD |
| MarketWatch | $1.44 Billion USD |
| marketcap.company | $1.44 Billion USD |
| Reuters | $1.44 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Clariane SE
Clariane SE provides care homes, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. It operates long-term care and short stay nursing homes. The company also provides inpatient and outpatient services, full-time hospitalization, day hospitalization, and outpatient care, and operates post-acute and rehabilitation care … Read more